Thatch Raises $108 Million in Funding to Revolutionize Employer-Sponsored Healthcare

Thatch, a health benefits platform, has announced a significant funding round of $108 million, raising its valuation to $1 billion. The funding came from notable investors such as The General Partnership, Index Ventures, General Catalyst, and Andreessen Horowitz, alongside several other companies. This substantial investment comes at a time when Thatch's revenue has experienced a remarkable seven-fold increase in the past year, and the platform is now being utilized by over 5,000 employers.

Thatch provides a unique solution to employers, allowing them to transition from traditional group health plans to a consumer-directed model, giving employees control over their healthcare spending. This shift in employer healthcare benefits represents a growing trend, demonstrating the increasing willingness of employers to move away from the conventional one-size-fits-all approach. The platform enables employers to allocate a defined health benefits budget, empowering employees to select individual health plans that best suit their specific needs, including doctors, prescriptions, family circumstances, and preferred coverage. This strategy not only provides employees with more control over their healthcare spending but also offers employers greater predictability in healthcare expenditure.

Thatch's innovative infrastructure facilitates the transition to individual coverage at scale, integrating with major health insurance carriers, payroll providers, and benefits platforms. The company's partnerships with industry leaders such as ADP, Paychex, Gusto, and QuickBooks further streamline the adoption of a consumer-directed healthcare model. Thatch's mission is to revolutionize the healthcare system by fundamentally changing the way it is funded, ultimately creating a healthcare system that people love.

The company's remarkable growth and investor confidence indicate a broader industry shift towards empowering individuals in their healthcare decision-making, potentially reshaping the future of healthcare funding and consumption.